Evidence map›Paper›PMID 36864519›Full record

ArticleActa neuropathologica communications2023

An integrated genetic analysis of epileptogenic brain malformed lesions.

Atsushi Fujita, Mitsuhiro Kato, Hidenori Sugano, Yasushi Iimura, Hiroharu Suzuki, Jun Tohyama, Masafumi Fukuda, Yosuke Ito, Shimpei Baba, Tohru Okanishi and 24 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Cell-type-resolved transcriptomic landscape of human focal cortical dysplasia.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 17 institutions in 1 country.

Atsushi FujitaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Mitsuhiro KatoDepartment of Pediatrics, Showa University School of Medicine, Tokyo, 142-8666, Japan.
Hidenori SuganoDepartment of Neurosurgery, Epilepsy Center, Juntendo University, Tokyo, 113-8421, Japan.
Yasushi IimuraDepartment of Neurosurgery, Epilepsy Center, Juntendo University, Tokyo, 113-8421, Japan.
Hiroharu SuzukiDepartment of Neurosurgery, Epilepsy Center, Juntendo University, Tokyo, 113-8421, Japan.
Jun TohyamaDepartment of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, 950-2085, Japan.
Masafumi FukudaDepartment of Functional Neurosurgery, Epilepsy Center, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, 950-2085, Japan.
Yosuke ItoDepartment of Functional Neurosurgery, Epilepsy Center, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, 950-2085, Japan.
Shimpei BabaDepartment of Child Neurology, Comprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, 430-8558, Japan.
Tohru OkanishiDivision of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, 683-8503, Japan.
Hideo EnokiDepartment of Pediatrics, Kawasaki Medical School, Kurashiki, 701-0192, Japan.
Ayataka FujimotoComprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, 430-8558, Japan.
Akiyo YamamotoDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, 060-8543, Japan.
Kentaro KawamuraDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, 060-8543, Japan.
Shinsuke KatoDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, 060-8543, Japan.
Ryoko HondaDepartment of Pediatrics, National Hospital Organization Nagasaki Medical Center, Omura, 856-8562, Japan.
Tomonori OnoEpilepsy Center, National Hospital Organization Nagasaki Medical Center, Omura, 856-8562, Japan.
Hideaki ShiraishiDepartment of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, 060-8638, Japan.
Kiyoshi EgawaDepartment of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, 060-8638, Japan.
Kentaro ShiraiDepartment of Pediatrics, Tsuchiura Kyodo General Hospital, Tsuchiura, 300-0028, Japan.
Shinji YamamotoDepartment of Neurosurgery, Tsuchiura Kyodo General Hospital, Tsuchiura, 300-0028, Japan.
Itaru HayakawaDivision of Neurology, National Center for Child Health and Development, Tokyo, 157-8535, Japan.
Hisashi KawawakiDepartment of Pediatric Neurology, Children's Medical Center, Osaka City General Hospital, Osaka, 534-0021, Japan.
Ken SaidaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Naomi TsuchidaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Yuri UchiyamaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Kohei HamanakaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Takeshi MizuguchiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Mitsuko NakashimaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Hirotomo SaitsuDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Noriko MiyakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Akiyoshi KakitaDepartment of Pathology, Brain Research Institute, Niigata University, Niigata, 951-8585, Japan.
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan. naomat@yokohama-cu.ac.jp.ORCID 0000-0001-9846-6500
Yokohama City University · JPJuntendo University · JPNational Hospital Organization · JPSapporo Medical University · JPYokohama City University Hospital · JPHamamatsu University School of Medicine · JPHokkaido University · JPNagasaki Medical Center · JPSeirei Hamamatsu General Hospital · JPTsuchiura Kyodo General Hospital · JPKawasaki Medical School · JPNational Center For Child Health and Development · JPNational Center for Global Health and Medicine · JPNiigata University · JPOsaka City General Hospital · JPShowa University · JPTottori University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Focal cortical dysplasia is the most common malformation during cortical development, sometimes excised by epilepsy surgery and often caused by somatic variants of the mTOR pathway genes. In this study, we performed a genetic analysis of epileptogenic brain malformed lesions from 64 patients with focal cortical dysplasia, hemimegalencephy, brain tumors, or hippocampal sclerosis. Targeted sequencing, whole-exome sequencing, and single nucleotide polymorphism microarray detected four germline and 35 somatic variants, comprising three copy number variants and 36 single nucleotide variants and indels in 37 patients. One of the somatic variants in focal cortical dysplasia type IIB was an in-frame deletion in MTOR, in which only gain-of-function missense variants have been reported. In focal cortical dysplasia type I, somatic variants of MAP2K1 and PTPN11 involved in the RAS/MAPK pathway were detected. The in-frame deletions of MTOR and MAP2K1 in this study resulted in the activation of the mTOR pathway in transiently transfected cells. In addition, the PTPN11 missense variant tended to elongate activation of the mTOR or RAS/MAPK pathway, depending on culture conditions. We demonstrate that epileptogenic brain malformed lesions except for focal cortical dysplasia type II arose from somatic variants of diverse genes but were eventually linked to the mTOR pathway.

Indexed as

Brain NeoplasmsFocal Cortical DysplasiaMalformations of Cortical Development, Group INervous System MalformationsBrainEpilepsyHumansFocal cortical dysplasiaLEATsmTORRAS/MAPKSomatic variants

Identifiers

PMID36864519
PMCPMC9983246
OpenAlexW4322765471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.